2019
Canadian Cancer Research Conference (by the CCRA: Canadian Cancer Research Alliance)
Ottawa, Ontario, October 2019
Name: Sze (Samuel) Chan
Presentation Type: Poster
Title: Systemic Inflammatory Markers of Survival in Epidermal Growth Factor (EGFR) Mutated Non-Small Cell Lung Cancer (NSCLC)
Name: Sze (Samuel) Chan
Presentation Type: Poster
Title: Factors Influencing Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors using Real World Data
Name: Sze (Samuel) Chan
Presentation Type: Poster
Title: Sites of Metastases and Lung Cancer Outcomes After Treatment with Immune Checkpoint Inhibitors
Name: Elliot Smith
Presentation Type: Poster
Title: Clinical Predictors of Hyperprogression in advanced NSCLC following PD-1/PD-L1 inhibitor initiation
Name: Kristen Dietrich
Presentation Type: Poster
Title: Routine Edmonton Symptom Assessment System (ESAS) Scores in epithelioid malignant pleural mesothelioma (eMPM) patients undergoing palliative systemic therapy
Name: Kathryn Corbett
Presentation Type: Poster
Title: Impact of depression and anxiety on cancer patients' perceptions of lifestyle behaviours
ASCO Supportive Care in Oncology Symposium
San Francisco, USA, October 2019
European Society for Medical Oncology (ESMO). European Cancer Conference (ECC) 2019
Name: Aline Fares
Presentation Type: Poster
Title: Sex, smoking status, body-mass index (BMI) at the time of non-small cell lung cancer diagnosis, and overall survival (OS):. A a pooled analysis of 14,396 International Lung Cancer Consortium (ILCCO) patients
Name: Lawson Eng
Presentation Type: Poster
Title: Tobacco Retail Availability and Tobacco Cessation Among Head and Neck Cancer (HNC) Survivors
Name: Reenika Aggarwal
Presentation Type: Poster
Title: Pre-operative serum artemin (ARTN) as a predictive biomarker of recurrence following curative resection for hepatocellular carcinoma (HCC)
Barcelona, Spain, Sept 2019
IASLC, 20th World Conference on Lung Cancer (WCLC)
Name: Erin Stewart
Presentation Type: Poster
Title: Genomic Profiling of Liquid Biopsies During 2nd/3rd Generation ALK Inhibitor Therapy to Identify Novel Mechanisms of Resistance
Name: Erin Stewart
Presentation Type: Poster
Title: Early, Subclinical SCLC Transformation in Patients with EGFR Mutant Lung Cancer Receiving Osimertinib, Detected Through Cell-Free DNA
Name: Erin Stewart
Presentation Type: Poster
Title: Tumor-Stromal Microenvironment Interactions in a PDX Model of EGFR TKI Drug Tolerance
Name: Sally Lau
Presentation Type: Poster
Title: A predominance of myeloid cells in peripheral blood associates with rapid progression and poor survival in advanced non-small cell lung cancer (NSCLC) patients who received first line treatment with PD-1/PD-L1 monotherapy
Name: Lawson Eng
Presentation Type: Poster
Title: Tobacco Retail Availability and Tobacco Cessation Among Lung Cancer Survivors
Barcelona, Sept 2019
ILCCO Annual Meeting
Name: Aline Fares
Presentation Type: Poster
Title: Performance of the patient reported CAPLET2.0 physical functioning assessment tool
Lyon, France
San Diego, CA, Sept. 2019
Name: Alex McCartney
Presentation Type: Poster
Title: Performance of the patient reported CAPLET2.0 physical functioning assessment tool
Name: Priya Bapat
Presentation Type: Poster
Title: Barriers and Facilitators to the Implementation of Routine Ototoxicity Screening for Head and Neck Cancer Patients
Name: Lorin Dodbiba
Presentation Type: Poster
Title: Comparing health utility scores, treatments, and outcomes in lung cancer patients with rare EGFR mutations with those with exon 19 deletion (del) and L858R mutations
Name: Andrew Lam
Presentation Type: Poster
Title: Quality improvement of lung cancer patient selection using clinic-based spirometry
ASCO Quality Care Symposium
San Diego, CA, Sept. 2019
International Conference on Pharmacoepidemiology (ISPE/ICPE).Annual Meeting
Name: Lidija Latifovic
Presentation Type: Poster
Title: Toxicity latent classes in chemotherapy-refractory, metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibody: latent class analysis of clinical trials data
Philadelphia, August 2019
Multinational Association of Supportive Care in Cancer (MASCC/ISOO
Name: Zhen (Jason) Fan
Presentation Type: Poster
Title: A REMOTE-SYMPTOM REPORTING (RSR) MOBILE APPLICATION FOR LUNG CANCER AND SARCOMA PATIENTS IN AN OUTPATIENT CLINIC: ENVIRONMENTAL SCAN AND READINESS ASSESSMENT
Name: Daniel Davies
Presentation Type: Poster
Title:Predictors Of Adherence To A Remote Web-based Symptom Monitoring Intervention
San Francisco, June 2019
UHN-DMOH-Annual Divisional Research Day
Name: Alex McCartney
Presentation Type: Poster
Title: Performance of the patient reported CAPLET2.0 physical functioning assessment too
Name: Andrew Lam
Presentation Type: Poster
Title: Improving participant selection for lung cancer screening with the addition of spirometry: an interim analysis
Name: Daniel Davies
Presentation Type: Poster
Title: PREDICTORS OF ADHERENCE TO REMOTE WEB-BASED SYMPTOM MONITORING INTERVENTION
Name: Elliot Smith
Presentation Type: Poster
Title: Clinical Predictors of Hyperprogression in Advanced NSCLC Following PD-1/PD-L1 Inhibitor Initiation
Name: Zhen (Jason) Fan
Presentation Type: Poster
Title: A Remote-Symptom Reporting Mobile Application for Lung Cancer and Sarcoma Patients in an Outpatient Clinic: Environmental Scan and Readiness Assessment
Name: Luna Zhan & Timjen Sachumsky
Presentation Type: Poster
Title: Ototoxicity in Cisplatin based chemotherapy in Head and Neck Cancer patients Prevalence Estimates and potential Risk factors
Name: Pansy Chow
Presentation Type: Poster
Title: Implementing Routine Ototoxicity Screening for Head and Neck Cancer Patients within the HN Translational Study
Name: Priya Bapat
Presentation Type: Poster
Title: Barriers and Facilitators to the Implementation of Routine Ototoxicity Screening for Head and Neck Cancer Patients
Name: Reenika Aggarwal
Presentation Type: Poster
Title: Identifying a high risk subpopulation within a lung cancer screening program via long term interval screening
Name: Richard Chen
Presentation Type: Poster
Title: Real-World Characterization of Cancer Patients Admitted with Immune-Related Adverse Events (irAEs)
Name: Shirley Jiang
Presentation Type: Poster
Title: Real-world Health Utility Scores and Toxicities to Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Advanced Non-small Cell Lung
Name: Shirley Jiang
Presentation Type: Oral
Title: Longitudinal Real-world Health Utility Scores and Toxicities to Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Advanced Non-small Cell Lung Cancer
Toronto, June 2019
Name: Sze (Sam) Chen
Presentation Type: Poster
Title: Lung Cancer Outcomes After Treatment with Immune Checkpoint Inhibitors
Name: Lawson Eng
Presentation Type: Oral
Title: Tobacco Retail Availability and Tobacco Cessation in Lung and Head and Neck (HN) Cancer Survivors
ASCO 2019
Chicago, USA, June 2019
Name: Aline Fusco Fares
Presentation Type: Poster
Title: Does ethnicity affect the relationship between body mass index (BMI) and overall survival (OS) in non-small cell lung cancer (NSCLC)? A pooled analysis of 17,326 International Lung Cancer Consortium (ILCCO) patients (pts).
Name: Di Maria Jiang
Presentation Type: Poster
Title: Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma (GEAC).
Name: Lawson Eng
Presentation Type: Poster
Title: Impact of health behavior change on health utility (HU) and financial toxicity in head and neck cancer (HNC) survivors.
Name: Sally CM Lau
Presentation Type: Poster
Title: Bone metastases as predictors of treatment response and rapidly progressive disease in NSCLC patients on PD-1/PD-L1 immune checkpoint inhibitors (ICI).
Name: Kirstin Perdrizet
Presentation Type: Poster
Title:Non-small cell lung cancer (NSCLC) next generation sequencing (NGS) using the Oncomine Comprehensive Assay (OCA) v3: Integrating expanded genomic sequencing into the Canadian publicly funded health care model.
Name: Sebastiao N. Martins-Filho
Presentation Type: Poster
Title: Clinical, pathological and genetic predictors of patient-derived xenograft (PDX) engraftment in EGFR-mutated lung adenocarcinoma (LUAD).
Name: Lawson Eng
Presentation Type: Poster
Title: Tobacco retail availability and tobacco cessation in lung and head and neck (HN) cancer survivors.
Name: Hadas Sorotsky
Presentation Type: Poster
Title: Quantifying EpCAM heterogeneity of circulating-tumor-cells (CTCs) from small cell lung cancer (SCLC) patients.
Name: Sally CM Lau
Presentation Type: Poster
Title: Myeloid immunosuppressive state as a predictor of rapidly progressive phenotype and poor survival in advanced non-small cell lung cancer (NSCLC) patients treated with PD-1/PD-L1 inhibitors.
Name: Jaspreet K Bajwa
Presentation Type: Poster
Title: Muscle wasting, visceral and subcutaneous adiposity, inflammation, nutritional deficiencies, and metastatic esophageal cancer (MEC) prognosis.
ASCO SITC meeting
February 2019
Name: RuiQui Chen
Presentation Type: Poster
Title: Comparison of care patterns for hospitalized immune-related adverse events (irAEs) between melanoma patients on combination immune checkpoint inhibitor (ICI) therapy versus ICI monotherapy.
ASCO GI meeting
January 2019
Name: Shirley Xue Jiang
Presentation Type: Poster
Title: The Esophageal Online Patient Reported Outcomes (EsO-PRO) Questionnaire: Formal implementation and assessment of a combined clinical and research data collection tool.
ESTRO 2019
T.S. Toh, A. Bang, D. Pinto, K. Hueniken, C. Brown, W.
Xu, G. Liu, B. Lok. Outcomes of IMRT/VMAT vs 2D/3D-conformal
thoracic radiation in limited stage small-cell lung
cancer. Radiotherapy and Oncology 2019; 133 (supp 1) abstr PO-0774